CRISPR Therapeutics AG

Norris Financial Group, LLC CRSP

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/20/2026

Shares

7,257

Value ($000)

345

Weight

0.1%

2022 Q1 - 2026 Q1 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/20/2026	345	0.1%	7,257	3/31/2026
2025 Q4	5/20/2026	411	0.1%	7,842	12/31/2025
2025 Q3	5/20/2026	515	0.2%	7,954	9/30/2025
2025 Q2	5/20/2026	473	0.2%	9,725	6/30/2025
2025 Q1	5/20/2026	329	0.2%	9,677	3/31/2025
2024 Q4	5/20/2026	258	0.1%	6,564	12/31/2024
2024 Q3	5/20/2026	486	0.2%	10,354	9/30/2024
2024 Q2	5/20/2026	546	0.3%	10,114	6/30/2024
2024 Q1	5/20/2026	856	0.5%	12,559	3/31/2024
2023 Q4	5/20/2026	931	0.6%	14,867	12/31/2023
2023 Q3	5/20/2026	656	0.5%	14,450	9/30/2023
2023 Q2	5/20/2026	679	0.5%	12,094	6/30/2023
2022 Q1	5/20/2026	220	0.1%	3,502	3/31/2022